SIMOVIL 20 MG

Country: ইস্রায়েল

ভাষা: ইংরেজি

সূত্র: Ministry of Health

সক্রিয় উপাদান:

SIMVASTATIN 20 MG

থেকে পাওয়া:

MERCK SHARP & DOHME ISRAEL LTD

এটিসি কোড:

C10AA01

ফার্মাসিউটিকাল ফর্ম:

TABLETS

প্রশাসন রুট:

PER OS

Manufactured by:

MERCK SHARP & DOHME B.V, HOLLAND

Therapeutic group:

SIMVASTATIN

থেরাপিউটিক ইঙ্গিত:

Coronary Heart Disease : In patients with coronary heart disease and hypercholesterolemia Simovil is indicated to: Reduce the risk of total mortality by reducing coronary death; Reduce the risk of non-fatal myocardial infarction; Reduce the risk for undergoing myocardial revascularization procedures; Reduce the risk of stroke and transient ischemic attacks (TIA). Hyperlipidemia: Simovil is indicated as an adjunct to diet to reduce elevated TOTAL-C LDL-C Apo B and TG and to increase HDL-C in patients with primary hypercholesterolemia( heterozygous familial and nonfamilial) and mixed dyslipidemia (Frederickson Types IIa and IIb) Simovil therefore lowers the LDL-C/HDL-C and the total-C/HDL-C ratios. Homozygous familial hypercholesterolemia: Simovil is also indicated as an adjunct to diet and other non-dietary measures in reducing elevated total cholesterol LDL-cholesterol and apolipoprotein B in patients with homozygous familial hypercholesterolemia when response to these measures is inadequate. Hypertriglycerid

অনুমোদন তারিখ:

2013-01-01